NASDAQ: ADXNAddex Therapeutics Ltd Earnings Dates, Reports, Calls
Addex Therapeutics earnings were -$7.6M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest ADXN earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$2.2M, up 34.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ADXN reported annual earnings of $7.8M, with -162.4% growth.
ADXN earnings history
Current Revenue
$204.0k
Current Earnings
-$7.4M
Current Profit Margin
-3,616.4%
ADXN Return on Equity
Current Company
-66.8%
Current Industry
-10.1%
Current Market
30.7%
ADXN's Return on Equity (-66.8%)... subscribe to Premium to read more.
High Return on Equity Performance
ADXN undefined
Current Company
-59.3%
Current Industry
-0.2%
ADXN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance
Be the first to know when ADXN announces earnings.
ADXN undefined
Current Company
-82.04%
Current Industry
6.4%
ADXN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance
ADXN vs Biotech Stocks
Addex Therapeutics Earnings Reports & History FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.